Kristina Fair
Gerontology · Rahway, NJNPI 1477984953
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,101 of the $4,653 with a category attached, or 88.1%. It is spread thinly across 32 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$875
- Pfizer$523
- Bayer$485
- Sumitomo Pharma America, Inc.$366
- AbbVie$329
- Astellas Pharma US Inc$266
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,10188%
- Education$55212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 38 | $875 |
| Pfizer | 28 | $523 |
| Bayer | 21 | $485 |
| Sumitomo Pharma America, Inc. | 22 | $366 |
| AbbVie | 16 | $329 |
| Astellas Pharma US Inc | 10 | $266 |
| AstraZeneca | 13 | $214 |
| Merck | 11 | $195 |
| 180 Medical, Inc. | 7 | $166 |
| Endo Pharmaceuticals Inc. | 8 | $122 |
| Endo USA, Inc. | 6 | $103 |
| Urovant Sciences Inc | 7 | $100 |
| Sun Pharmaceutical Industries Inc. | 2 | $95 |
| Tolmar, Inc. | 5 | $91 |
| Dendreon Pharmaceuticals LLC | 5 | $87 |
| Seagen Inc. | 1 | $85 |
| Progenics Pharmaceuticals, Inc. | 4 | $79 |
| Novartis | 5 | $74 |
| Boston Scientific | 3 | $54 |
| Hollister Incorporated | 3 | $54 |
| Immunitybio, Inc. | 3 | $52 |
| Davol Inc. | 1 | $51 |
| Urogen Pharma, Inc. | 2 | $32 |
| Telix Pharmaceuticals | 2 | $30 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $19 |
| Axonics, Inc. | 1 | $17 |
| Blue Earth Diagnostics | 1 | $15 |
| Tolmar Pharmaceuticals, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Sanofi | 1 | $12 |
| Myriad Genetic Laboratories, Inc. | 1 | $11 |
How this compares
$4,653 in reported general payments places this provider in the 95th percentile of 374 gerontology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 151 | $137,443 |
| MyrbetriqMirabegron | 97 | $80,751 |
| ElmironPentosan Polysulfate Sodium | 12 | $12,586 |
| Testosterone | 28 | $8,994 |
| Tamsulosin Hcl | 324 | $5,211 |
| Methenamine Hippurate | 11 | $1,977 |
| Silodosin | 16 | $1,928 |
| Finasteride | 109 | $1,578 |
| Potassium Citrate ErPotassium Citrate | 20 | $809 |
| Trospium Chloride | 14 | $779 |
| NitrofurantoinNitrofurantoin Macrocrystal | 32 | $672 |
| Desmopressin Acetate | 15 | $671 |
| Oxybutynin Chloride ErOxybutynin Chloride | 19 | $441 |
| CefuroximeCefuroxime Axetil | 43 | $411 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 17 | $328 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $366 | $137,443151 claims |
| Astellas Pharma US IncMyrbetriq | $266 | $80,75197 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 374 gerontology providers in New Jersey.
Other gerontology in Rahway
- Marilou NeylonRahway$6K
- Dana JonesTeaneck$150K
- Jennifer FoxFlemington$76K
- Susan HermidaBrick$33K
- Jihane SaadeNorth Bergen$9K
- Joseph RudolphCamden$8K
- Jennifer LernerNew Brunswick$7K
- Josephine MachadoNew Brunswick$7K
- Remya JamesNew Brunswick$7K
- Anna HaEnglewood$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.